![BIOPORTO A/S [CBOE]](/medias/logo_company/HlEyj5vMm9wAUKs.png "BIOPORTO A/S [CBOE]"){kind=logo}
BIOPORTO A/S [CBOE] news, videos and press releases
For more news please use our advanced search feature.
BIOPORTO A/S [CBOE] - More news...
BIOPORTO A/S [CBOE] - More news...
- Grant of warrants
- BioPorto A/S Appoints Chief Legal Officer
- New Board Candidate for the upcoming Annual Geneal Meeting
- Notice convening the Annual General Meeting in BioPorto A/S
- Correction: BioPorto Announces Annual Results for 2023
- BioPorto Announces Annual Results for 2023
- BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer
- BioPorto announces preliminary results for 2023 and provides strategic update for the period 2024-2026
- Roche Diagnostics and BioPorto expand collaboration
- BioPorto implements changes to the Executive Management.
- Managers’ transactions
- BioPorto Receives FDA 510(k) Clearance for NGAL Test in the United States First Test to Aid in Assessing AKI Risk for Patients Aged 3 Months Through 21 Years
- Resignation of Director
- BioPorto Announces Interim Results and Business Update For the Third Quarter and Nine Months of Fiscal 2023
- BioPorto provides interim Q3 results and revised 2023 Financial Guidance.
- Grant of Warrants
- BioPorto Initiates Search for new CFO as Neil Goldman Resigns
- BioPorto Announces Interim Results for the First Six Months of 2023
- Managers’ transactions
- BioPorto A/S announces completion of rights issue; total number of shares and voting rights
- BioPorto A/S announces results of rights issue
- BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed pursuant to advance commitments
- Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act
- BioPorto Announces Interim Results for the First Three Months of 2023
- Resolutions of the General Meeting of BioPorto A/S
- Grant of Warrants
- Notice convening the Annual General Meeting in BioPorto A/S
- BioPorto Announces Annual Results for the Year ended December 31, 2022
- BioPorto Announces Financial Guidance for 2023
- US healthcare executive Dr. Ninfa Saunders, DHA, MVA, MSN, FACHE and other Board members to be nominated at general meeting; Chris Lindop not standing for re-election.
